Biosurveillance Mandates Drive Biological Detection Demand
Governments are steadily specifying biological detection capability across new defense and homeland security programs, a shift driven by post-pandemic biosurveillance economics and rapid-response public health integration rather than defense mandate alone. This transition demands entirely new biosensor and rapid-assay qualification pathways designed specifically for continuous biological monitoring, a genuinely different engineering problem than the chemical agent detection that has defined the category for decades. Suppliers building this capability today are positioning themselves ahead of a shift expected to accelerate considerably as more governments publish measurable biosurveillance investment targets across their defense programs.
Market Impact: Sustains 52 percent sustainment share








